宜宾隆鼻美容手术-【宜宾韩美整形】,yibihsme,宜宾市埋线式双眼皮副作用,宜宾韩美医院祛斑怎样,宜宾知名隆胸医院,宜宾简单丰胸,宜宾丰胸最好的医院,宜宾哪里有双眼皮的

BEIJING, March 28 (Xinhuanet) -- Google Inc. is working with MasterCard Inc. and Citigroup Inc to develop a technology that could make mobile payments, according to media reports Monday.The new technology named "Nexus S Android" is embedded in Android mobile devices and allows customers to make purchases by waving their smartphones in front of a small reader at the checkout counter.Credit-card reader producer VeriFone Systems Inc, also involved in the new payment service, is developing contact-less devices that could allow people to pay with a wave or tap of credit card or a tap of smartphone.To use the service, holders of Citigroup-issued debit and credit cards must activate a mobile-payment application developed for one current model of Android phones. More models will be coming as the technology advances.Besides mobile payment, consumers would also be able to get targeted ads or discount offers, manage credit-card accounts and track spending through an application on their smartphones.Due to the deliberate design of the technology, customers have no need to worry about the security of their payment information. Nick Holland, a mobile-transactions analyst at Yankee Group, said the new technology is more sophisticated than credit cards with a magnetic stripe.With the coming service, Google is aiming to boost its advertising business by offering retailers more data about their customers and help them target ads and discount offers to mobile-device users near their stores.An insider told that Google was not expected to get a cut of the transaction fees.The service is expected to be released this year. Once released, it will broaden the uses of smartphones for everyday activities—from chatting to emailing to shopping.
WELLINGTON, May 27 (Xinhua) -- Eating kiwifruit might be a much better way of getting vitamin C into your system than taking purified vitamin supplements, according to research from New Zealand.Researchers with the University of Otago found that in mice eating kiwifruit, vitamin C uptake was five times as effective as taking a purified supplement form.The study was published in the American Journal of Clinical Nutrition, the highest ranking journal for human nutrition research, said a statement from the university.Lead researcher Associate Professor Margreet Vissers said people required vitamin C (ascorbate) in all body tissues and organs to be healthy, but the only source of vitamin C was through food or in purified form, arguably the most commonly consumed vitamin supplement.In the experiment vitamin C-deficient mice were fed the vitamin over a month, either as kiwifruit or as an equivalent amount of pure vitamin C, said the statement.Mice fed the kiwifruit absorbed vitamin C much more efficiently than those given the purified supplement form, and they also retained it for longer, indicating something in the fruit improved absorption and retention."The findings of the mouse trial have important implications for human nutrition," said Vissers."The question that has often been asked is whether a supplement is as good a source of vitamin C as whole foods, but few studies have addressed this issue. We are uniquely placed to do that work. "An equivalent human study was underway to determine whether the situation also applied to people, said the statement.The mouse study was funded by the university and kiwifruit marketing firm Zespri.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.
JAKARTA, April 27 (Xinhua) -- Marine scientists will begin conducting an ecological survey in eight locations throughout the resort island in Indonesia's Bali province that could be developed as marine managed areas due to their biodiversity and coral structure, the Jakarta Post quoted an expert as saying on Wednesday.The survey, which will take place from April 29 to May 11, will be carried out by four international scientists and local scientists from universities.Ketut Sarjana Putra, the marine program director with Conservation International Indonesia, said Tuesday the survey was aimed at identifying marine species and their population in each of the eight locations.Selected from 25 potential marine conservation zones, the eight locations are Pulaki and Pemuteran, Lovina, Les Village, Tulamben and Amed, Padangbai, Nusa Penida, Bukit Uluwatu Peninsula and Perancak Beach. "We will go around Bali, starting from Sanur in the south, heading east, then covering the northern and the western areas, then back to the south," Ketut told the daily.The survey is part of a process to build a network of marine protected areas to effectively manage the island's marine and coastal resources to sustain environmental and socioeconomic value and benefits, with priority given to the eight locations.
BEIJING, Jan. 26 (Xinhua) -- China remained a major victim of trade protectionism during the past year, witnessing 64 trade disputes in this period, covering some 7 billion U.S. dollars in value, China's Vice Commerce Minister, Zhong Shan, said here Wednesday.The country faced trade disputes with both developed countries and developing ones, which came from not only traditional sectors but also high-tech industries, he told a national conference on trade promotion.For the short- and mid-term, China would work to maintain a stable growth in foreign trade and keep the growth rate higher than both the global level and China's economic growth, he said.China would also strive to achieve a more balanced trade structure by boosting imports and outbound investment, to strengthen the quality and efficiency of foreign trade, he added.China's foreign trade last year jumped 34.7 percent year on year to more than 2.97 trillion U.S. dollars, while its trade surplus fell 6.4 percent to 183.1 billion U.S. dollars.
来源:资阳报